a trend towards significancep <0.0001
6 In contrast, Khan et al did not confirm the advantage of RARC in terms of EBL (RARC 585 ml vs ORC 808 ml; p=0.070), even if a trend towards significance was observed. 7 Finally, the RAZOR trial showed the advantage of RARC in terms of EBL (RARC 300 ml vs ORC 700 ml; p <0.0001), describing lower intra- (RARC 13% vs ORC 34%; p <0.0001) and postoperative (RARC 25% vs ORC 40%; p=0.0089) transfusion rates. 8 Our study confirmed significantly lower transfusions rates in the RARC cohort, with comparable intraoperative and a trend towards significantly lower postoperative transfusion rates.